|
1
|
Russo A, Cardile V, Graziano ACE, Avola R,
Montenegro I, Cuellar M, Villena J and Madrid A: Antigrowth
activity and induction of apoptosis in human melanoma cells by
Drymis winteri forst extract and its active components. Chem Biol
Interact. 305:79–85. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yuan R, Hou Y, Sun W, Yu J, Liu X, Niu Y,
Lu JJ and Chen X: Natural products to prevent drug resistance in
cancer chemotherapy: A review. Ann N Y Acad Sci. 1401:19–27. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sung H, Ferlay J, Siegel RL, Laversanne M,
Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020:
GLOBOCAN estimates of incidence and mortality worldwide for 36
cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Hung KC, Huang TC, Cheng CH, Cheng YW, Lin
DY, Fan JJ and Lee KH: The expression profile and prognostic
significance of metallothionein genes in colorectal cancer. Int J
Mol Sci. 20:38492019. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gao L, Yang T, Xue Z and Chan CKD: Hot
spots and trends in the relationship between cancer and obesity: A
systematic review and knowledge graph analysis. Life (Basel).
13:3372023.PubMed/NCBI
|
|
6
|
Baskar R, Lee KA, Yeo R and Yeoh KW:
Cancer and radiation therapy: Current advances and future
directions. Int J Med Sci. 9:193–199. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang X, Zhang H and Chen X: Drug
resistance and combating drug resistance in cancer. Cancer Drug
Resist. 2:141–160. 2019.PubMed/NCBI
|
|
8
|
Ramos A, Sadeghi S and Tabatabaeian H:
Battling chemoresistance in cancer: Root causes and strategies to
uproot them. Int J Mol Sci. 22:94512021. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Vasseur S and Guillaumond F: Lipids in
cancer: A global view of the contribution of lipid pathways to
metastatic formation and treatment resistance. Oncogenesis.
11:462022. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Newman DJ and Cragg GM: Natural products
as sources of new drugs from 1981 to 2014. J Nat Prod. 79:629–661.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bishayee A and Sethi G: Bioactive natural
products in cancer prevention and therapy: Progress and promise.
Semin Cancer Biol. 40–41. 1–3. 2016.PubMed/NCBI
|
|
12
|
Akter R, Afrose A, Rahman MR, Chowdhury R,
Nirzhor SSR, Khan RI and Kabir MT: A comprehensive analysis into
the therapeutic application of natural products as SIRT6 modulators
in alzheimer's disease, aging, cancer, inflammation, and diabetes.
Int J Mol Sci. 22:41802021. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wei J, Liu H, Liu M, Wu N, Zhao J, Xiao L,
Han L, Chu E and Lin X: Oleanolic acid potentiates the antitumor
activity of 5-fluorouracil in pancreatic cancer cells. Oncol Rep.
28:1339–1345. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Sultana N and Ata A: Oleanolic acid and
related derivatives as medicinally important compounds. J Enzyme
Inhib Med Chem. 23:739–756. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baer-Dubowska W, Narożna M and
Krajka-Kuźniak V: Anti-cancer potential of synthetic oleanolic acid
derivatives and their conjugates with NSAIDs. Molecules.
26:49572021. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu J: Oleanolic acid and ursolic acid:
Research perspectives. J Ethnopharmacol. 100:92–94. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Prasad S, Kalra N and Shukla Y:
Hepatoprotective effects of lupeol and mango pulp extract of
carcinogen induced alteration in Swiss albino mice. Mol Nutr Food
Res. 51:352–359. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Singh GB, Singh S, Bani S, Gupta BD and
Banerjee SK: Anti-inflammatory activity of oleanolic acid in rats
and mice. J Pharm Pharmacol. 44:456–458. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Pádua TA, de Abreu BSSC, Costa TEMM,
Nakamura MJ, Valente LMM, Henriques MDG, Siani AC and Rosas EC:
Anti-inflammatory effects of methyl ursolate obtained from a
chemically derived crude extract of apple peels: Potential use in
rheumatoid arthritis. Arch Pharm Res. 37:1487–1495. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Alqahtani A, Hamid K, Kam A, Wong KH,
Abdelhak Z, Razmovski-Naumovski V, Chan K, Li KM, Groundwater PW
and Li GQ: The pentacyclic triterpenoids in herbal medicines and
their pharmacological activities in diabetes and diabetic
complications. Curr Med Chem. 20:908–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Teodoro T, Zhang L, Alexander T, Yue J,
Vranic M and Volchuk A: Oleanolic acid enhances insulin secretion
in pancreatic beta-cells. FEBS Lett. 582:1375–1380. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Yu F, Wang Q, Zhang Z, Peng Y, Qiu Y, Shi
Y, Zheng Y, Xiao S, Wang H, Huang X, et al: Development of
oleanane-type triterpenes as a new class of HCV entry inhibitors. J
Med Chem. 56:4300–4319. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Cichewicz RH and Kouzi SA: Chemistry,
biological activity, and chemotherapeutic potential of betulinic
acid for the prevention and treatment of cancer and HIV infection.
Med Res Rev. 24:90–114. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Martín R, Carvalho-Tavares J, Hernández M,
Arnés M, Ruiz-Gutiérrez V and Nieto ML: Beneficial actions of
oleanolic acid in an experimental model of multiple sclerosis: A
potential therapeutic role. Biochem Pharmacol. 79:198–208. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Zhao X, Liu M and Li D: Oleanolic acid
suppresses the proliferation of lung carcinoma cells by
miR-122/Cyclin G1/MEF2D axis. Mol Cell Biochem. 400:1–7. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mu DW, Guo HQ, Zhou GB, Li JY and Su B:
Oleanolic acid suppresses the proliferation of human bladder cancer
by Akt/mTOR/S6K and ERK1/2 signaling. Int J Clin Exp Pathol.
8:13864–13870. 2015.PubMed/NCBI
|
|
27
|
Potočnjak I, Šimić L, Vukelić I, Batičić L
and Domitrović R: Oleanolic acid induces HCT116 colon cancer cell
death through the p38/FOXO3a/Sirt6 pathway. Chem Biol Interact.
363:1100102022. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhou R, Zhang Z, Zhao L, Jia C, Xu S, Mai
Q, Lu M, Huang M, Wang L, Wang X, et al: Inhibition of mTOR
signaling by oleanolic acid contributes to its anti-tumor activity
in osteosarcoma cells. J Orthop Res. 29:846–852. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Guo G, Yao W, Zhang Q and Bo Y: Oleanolic
acid suppresses migration and invasion of malignant glioma cells by
inactivating MAPK/ERK signaling pathway. PLoS One. 8:e720792013.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Wang X, Bai H, Zhang X, Liu J, Cao P, Liao
N, Zhang W, Wang Z and Hai C: Inhibitory effect of oleanolic acid
on hepatocellular carcinoma via ERK-p53-mediated cell cycle arrest
and mitochondrial-dependent apoptosis. Carcinogenesis.
34:1323–1330. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wei J, Liu M, Liu H, Wang H, Wang F, Zhang
Y, Han L and Lin X: Oleanolic acid arrests cell cycle and induces
apoptosis via ROS-mediated mitochondrial depolarization and
lysosomal membrane permeabilization in human pancreatic cancer
cells. J Appl Toxicol. 33:756–765. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu J, Zheng L, Wu N, Ma L, Zhong J, Liu
G, Ma L, Zhong J, Liu G and Lin X: Oleanolic acid induces metabolic
adaptation in cancer cells by activating the AMP-activated protein
kinase pathway. J Agric Food Chem. 62:5528–5537. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Liu J, Wu N, Ma LN, Zhong JT, Liu G, Zheng
LH and Lin XK: p38 MAPK signaling mediates mitochondrial apoptosis
in cancer cells induced by oleanolic acid. Asian Pac J Cancer Prev.
15:4519–4525. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HF, Wang XA, Xiang SS, Hu YP, Jiang L,
Shu YJ, Li ML, Wu XS, Zhang F, Ye YY, et al: Oleanolic acid induces
mitochondrial-dependent apoptosis and G0/G1 phase arrest in
gallbladder cancer cells. Drug Des Devel Ther. 9:3017–3030. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Li X, Song Y, Zhang P, Zhu H, Chen L, Xiao
Y and Xing Y: Oleanolic acid inhibits cell survival and
proliferation of prostate cancer cells in vitro and in vivo through
the PI3K/Akt pathway. Tumour Biol. 37:7599–7613. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Xu Y, Shu B, Tian Y, Wang G, Wang Y, Wang
J and Dong Y: Oleanolic acid induces osteosarcoma cell apoptosis by
inhibition of Notch signaling. Mol Carcinog. 57:896–902. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Guo Y, Han B, Luo K, Ren Z, Cai L and Sun
L: NOX2-ROS-HIF-1α signaling is critical for the inhibitory effect
of oleanolic acid on rectal cancer cell proliferation. Biomed
Pharmacother. 85:733–739. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li Y, Xu Q, Yang W, Wu T and Lu X:
Oleanolic acid reduces aerobic glycolysis-associated proliferation
by inhibiting yes-associated protein in gastric cancer cells. Gene.
712:1439562019. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Duan L, Yang Z, Jiang X, Zhang J and Guo
X: Oleanolic acid inhibits cell proliferation migration and
invasion and induces SW579 thyroid cancer cell line apoptosis by
targeting forkhead transcription factor A. Anticancer Drugs.
30:812–820. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kim GJ, Jo HJ, Lee KJ, Choi JW and An JH:
Oleanolic acid induces p53-dependent apoptosis via the ERK/JNK/AKT
pathway in cancer cell lines in prostatic cancer xenografts in
mice. Oncotarget. 9:26370–26386. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu X, Li Y, Yang W, Tao M, Dai Y, Xu J and
Xu Q: Inhibition of NF-κB is required for oleanolic acid to
downregulate PD-L1 by promoting DNA demethylation in gastric cancer
cells. J Biochem Mol Toxicol. 35:e226212021. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Zeng Z, Yu J, Jiang Z and Zhao N:
Oleanolic acid (OA) targeting UNC5B inhibits proliferation and EMT
of ovarian cancer cell and increases chemotherapy sensitivity of
niraparib. J Oncol. 2022:58876712022. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ren J, Yan J, Raza F, Zafar H, Wan H, Chen
X, Cui Q, Li H and Wang X: A synergistic combination of oleanolic
acid and apatinib to enhance antitumor effect on liver cancer cells
and protect against hepatic injury. Recent Pat Anticancer Drug
Discov. 19:199–208. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Hosny S, Sahyon H, Youssef M and Negm A:
Oleanolic acid suppressed DMBA-induced liver carcinogenesis through
induction of mitochondrial-mediated apoptosis and autophagy. Nutr
Cancer. 73:968–982. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Tang ZY, Li Y, Tang YT, Ma XD and Tang ZY:
Anticancer activity of oleanolic acid and its derivatives: Recent
advances in evidence, target profiling and mechanisms of action.
Biomed Pharmacother. 145:1123972022. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Liang Z, Pan R, Meng X, Su J, Guo Y, Wei
G, Zhang Z and He K: Transcriptome study of oleanolic acid in the
inhibition of breast tumor growth based on high-throughput
sequencing. Aging (Albany NY). 13:22883–22897. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Wang H, Zhong W, Zhao J, Zhang H, Zhang Q,
Liang Y, Chen S, Liu H, Zong S, Tian Y, et al: Oleanolic acid
inhibits epithelial-mesenchymal transition of hepatocellular
carcinoma by promoting iNOS dimerization. Mol Cancer Ther.
18:62–74. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Bednarczyk-Cwynar B, Wachowiak N, Szulc M,
Kamińska E, Bogacz A, Bartkowiak-Wieczorek J, Zaprutko L and
Mikolajczak PL: Strong and long-lasting antinociceptive and
anti-inflammatory conjugate of naturally occurring oleanolic acid
and aspirin. Front Pharmacol. 7:2022016. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Feng H, Wu YQ, Xu YS, Wang KX, Qin XM and
Lu YF: LC-MS-based metabolomic study of oleanolic acid-induced
hepatotoxicity in mice. Front Pharmacol. 11:7472020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Liu Y, Luo X, Xu X, Gao N and Liu X:
Preparation, characterization and in vivo pharmacokinetic study of
PVP-modified oleanolic acid liposomes. Int J Pharm. 517:1–7. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Li L, Wei L, Shen A, Chu J, Lin J and Peng
J: Oleanolic acid modulates multiple intracellular targets to
inhibit colorectal cancer growth. Int J Oncol. 47:2247–2254. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li L, Lin J, Sun G, Wei L, Shen A, Zhang M
and Peng J: Oleanolic acid inhibits colorectal cancer angiogenesis
in vivo and in vitro via suppression of STAT3 and
Hedgehog pathways. Mol Med Rep. 13:5276–5282. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Jiang X, Shi M, Sui M, Yuan Y, Zhang S,
Xia Q and Zhao K: Oleanolic acid inhibits cervical cancer Hela cell
proliferation through modulation of the ACSL4 ferroptosis signaling
pathway. Biochem Biophys Res Commun. 545:81–88. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372:n712021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Page MJ, Moher D, Bossuyt PM, Boutron I,
Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: PRISMA 2020 explanation and elaboration: Updated
guidance and exemplars for reporting systematic reviews. BMJ.
372:n1602021. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Richardson WS, Wilson MC, Nishikawa J and
Hayward RS: The well-built clinical question: A key to
evidence-based decisions. ACP J Club. 123:A12–A13. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Hooijmans CR, Rovers MM, de Vries RBM,
Leenaars M, Ritskes-Hoitinga M and Langendam MW: SYRCLE's risk of
bias tool for animal studies. BMC Med Res Methodol. 14:432014.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Higgins JPT, Thomas J, Chandler J,
Cumpston M, Li T, Page MJ and Welch VA: Cochrane handbook for
systematic reviews of interventions version 6.2 [updated February
2021]. Cochrane. 2021.Available from:. https://training.cochrane.org/handbook
|
|
59
|
Cao LM, Sun ZX, Makale EC, Du GK, Long WF
and Huang HR: Antitumor activity of fucoidan: A systematic review
and meta-analysis. Transl Cancer Res. 10:5390–5405. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Vesterinen HM, Sena ES, Egan KJ, Hirst TC,
Churolov L, Currie GL, Antonic A, Howells DW and Macleod MR:
Meta-analysis of data from animal studies: a practical guide. J
Neurosci Methods. 221:92–102. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Tang S, Gao D, Zhao T, Zhou J and Zhao X:
An evaluation of the anti-tumor efficacy of oleanolic acid-loaded
PEGylated liposomes. Nanotechnology. 24:2351022013. View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Niu G, Sun L, Pei Y and Wang D: Oleanolic
acid inhibits colorectal cancer angiogenesis by blocking the VEGFR2
signaling pathway. Anticancer Agents Med Chem. 18:583–590. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Lee JH, Yoo ES, Han SH, Jung GH, Han EJ,
Jung SH, Kim BS, Cho SD, Nam JS, Choi C, et al: Oleanolic acid
induces apoptosis and autophagy via the PI3K/AKT/mTOR pathway in
AGS human gastric cancer cells. J Funct Foods. 87:1048542021.
View Article : Google Scholar
|
|
64
|
Gao YS, Yuan Y, Song G and Lin SQ:
Inhibitory effect of ursolic acid and oleanolic acid from
Eriobotrya fragrans on A549 cell viability in vivo. Genet Mol Res.
15:2016. View Article : Google Scholar
|
|
65
|
Woo JS, Yoo ES, Kim SH, Lee JH, Han SH,
Jung SH, Jung GH and Jung JY: Anticancer effects of oleanolic acid
on human melanoma cells. Chem Biol Interact. 347:1096192021.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Nie H, Wang Y, Qin Y and Gong XG:
Oleanolic acid induces autophagic death in human gastric cancer
cells in vitro and in vivo. Cell Biol Int. 40:770–778. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Liu J, Liu Y, Madhu C and Klaassen CD:
Protective effects of oleanolic acid on acetaminophen-induced
hepatotoxicity in mice. J Pharmacol Exp Ther. 266:1607–1613.
1993.PubMed/NCBI
|
|
68
|
Žiberna L, Šamec D, Mocan A, Nabavi SF,
Bishayee A, Farooqi AA, Sureda A and Nabavi SM: Oleanolic acid
alters multiple cell signaling pathways: implication in cancer
prevention and therapy. Int J Mol Sci. 18:6432017. View Article : Google Scholar
|
|
69
|
Zhong YY, Chen HS, Wu PP, Zhang BJ, Yang
Y, Zhu QY, Zhang CG and Zhao SQ: Synthesis and biological
evaluation of novel oleanolic acid analogues as potential
α-glucosidase inhibitors. Eur J Med Chem. 164:706–716. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
70
|
Yang R, Huang X, Dou J, Zhai G and Su L:
Self-microemulsifying drug delivery system for improved oral
bioavailability of oleanolic acid: Design and evaluation. Int J
Nanomedicine. 8:2917–2926. 2013.PubMed/NCBI
|
|
71
|
Tang C, Chen Y, Bai S and Yang G: Advances
in the study of structural modification and biological activities
of oleanolic acid. Chin J Org Chem. 33:46–65. 2013. View Article : Google Scholar
|
|
72
|
Jiang Q, Yang X, Du P, Zhang H and Zhang
T: Dual strategies to improve oral bioavailability of oleanolic
acid: Enhancing water-solubility, permeability and inhibiting
cytochrome P450 isozymes. Eur J Pharm Biopharm. 99:65–72. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Gao N, Guo M, Fu Q and He Z: Application
of hot melt extrusion to enhance the dissolution and oral
bioavailability of oleanolic acid. Asian J Pharm Sci. 12:66–72.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Xia X, Liu H, Lv H, Zhang J, Zhou J and
Zhao Z: Preparation, characterization, and in vitro/vivo studies of
oleanolic acid-loaded lactoferrin nanoparticles. Drug Des Devel
Ther. 11:1417–1427. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Wei CT, Wang YW, Wu YC, Lin LW, Chen CC,
Chen CY and Kuo SM: Reparative efficacy of liposome-encapsulated
oleanolic acid against liver inflammation induced by fine ambient
particulate matter and alcohol in mice. Pharmaceutics. 14:11082022.
View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Lu Y, Zheng W, Lin S, Guo F, Zhu Y, Wei Y,
Liu X, Jin S, Jin L and Li Y: Identification of an oleanane-type
triterpene hedragonic acid as a novel farnesoid X receptor ligand
with liver protective effects and anti-inflammatory activity. Mol
Pharmacol. 93:63–72. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Li Y, Yu Y, Jin K, Gao L, Luo T, Sheng L,
Shao X and Li J: Synthesis and biological evaluation of novel
thiadiazole amides as potent Cdc25B and PTP1B inhibitors. Bioorg
Med Chem Lett. 24:4125–4128. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Feng MT, Wang T, Liu AH, Li J, Yao LG,
Wang B, Guo YW and Mao SC: PTP1B inhibitory and cytotoxic C-24
epimers of Δ28−24-hydroxy stigmastane-type steroids from
the brown alga Dictyopteris undulata Holmes. Phytochemistry.
146:25–35. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
79
|
de Oliveira TV, Stein R, de Andrade DF and
Beck RCR: Preclinical studies of the antitumor effect of
curcumin-loaded polymeric nanocapsules: A systematic review and
meta-analysis. Phytother Res. 36:3202–3214. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Maganti HB, Kirkham AM, Bailey AJM, Shorr
R, Kekre N, Pineault N and Allan DS: Use of CRISPR/Cas9 gene
editing to improve chimeric antigen-receptor T cell therapy: A
systematic review and meta-analysis of preclinical studies.
Cytotherapy. 24:405–412. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Singh D, Gupta M, Sarwat M and Siddique
HR: Apigenin in cancer prevention and therapy: A systematic review
and meta-analysis of animal models. Crit Rev Oncol Hematol.
176:1037512022. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Sun JY, Zhang D, Wu S, Xu M, Zhou X, Lu XJ
and Ji J: Resistance to PD-1/PD-L1 blockade cancer immunotherapy:
Mechanisms, predictive factors, and future perspectives. Biomark
Res. 8:352020. View Article : Google Scholar : PubMed/NCBI
|
|
83
|
Luo QW, Yao L, Li L, Yang Z, Zhao MM,
Zheng YZ, Zhuo FF, Liu TT, Zhang XW, Liu D, et al: Inherent
capability of self-assembling nanostructures in specific proteasome
activation for cancer cell pyroptosis. Small. 19:e22055312023.
View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Zhou Z, Song Q, Yang Y, Wang L and Wu Z:
Comprehensive landscape of RRM2 with immune infiltration in
pan-cancer. Cancers (Basel). 14:29382022. View Article : Google Scholar : PubMed/NCBI
|
